| [1] |
张玉顺, 宋志远, 朱鲜阳, 等. 卵圆孔未闭与心脑血管疾病[M]. 北京:科学出版社, 2016.
|
| [2] |
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts[J]. Mayo Clin Proc, 1984, 59(1):17-20.
|
| [3] |
Nellessen U, Daniel WG, Matheis G, et al. Impending paradoxical embolism from atrial thrombus: correct diagnosis by transesophageal echocardiography and prevention by surgery[J]. J Am Coll Cardiol, 1985, 5(4):1002-1004.
|
| [4] |
Brogno D, Lancaster G, Rosenbaum M. Embolism interruptus[J]. N Engl J Med, 1994, 330(24):1761-1762.
|
| [5] |
Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism[J]. Circulation, 1992, 86(6):1902-1908.
|
| [6] |
Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients[J]. Stroke, 1997, 28(12):2376-2381.
|
| [7] |
Meier B. Patent foramen ovale and closure technique with the amplatzer occluder[J]. Scientifica (Cairo), 2014, 2014:129196.
|
| [8] |
中国心血管健康与疾病报告2020[J]. 心肺血管病杂志, 2021, 40(9):885-889.
|
| [9] |
Pristipino C, Sievert H, D'Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism[J]. Eur Heart J, 2019, 40(38):3182-3195.
|
| [10] |
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association[J]. Stroke, 2021, 52(7):e364-e467.
|
| [11] |
张玉顺, 蒋世良, 朱鲜阳. 卵圆孔未闭相关卒中预防中国专家指南[J]. 心脏杂志, 2021, 33(1):1-10.
|
| [12] |
Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale[J]. N Engl J Med, 2012, 366(11):991-999.
|
| [13] |
Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke[J]. N Engl J Med, 2013, 368(12):1092-1100.
|
| [14] |
Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism[J]. N Engl J Med, 2013, 368(12):1083-1091.
|
| [15] |
史雪莉. 卵圆孔未闭介入封堵治疗相关新进展[J]. 中国循环杂志, 2019, 34(3):301-304.
|
| [16] |
何璐, 张玉顺. 封堵卵圆孔未闭预防卒中的国外发展及中国现状[J]. 协和医学杂志, 2021, 12(3):318-321.
|
| [17] |
Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke[J]. N Engl J Med, 2017, 377(11):1011-1021.
|
| [18] |
Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke[J]. N Engl J Med, 2017, 377(11):1033-1042.
|
| [19] |
Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke[J]. N Engl J Med, 2017, 377(11):1022-1032.
|
| [20] |
Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial[J]. J Am Coll Cardiol, 2018, 71(20):2335-2342.
|
| [21] |
Lattanzi S, Brigo F, Cagnetti C, et al. Patent foramen ovale and cryptogenic stroke or transient ischemic attack: to close or not to close? A systematic review and Meta-analysis[J]. Cerebrovasc Dis, 2018, 45(5-6):193-203.
|
| [22] |
张炜, 赵文娟, 王昱, 等. 介入治疗与利伐沙班抗凝治疗对伴卵圆孔未闭的隐源性卒中患者长期疗效的比较[J]. 天津医药, 2019, 47(8):847-850.
|